Navigation Links
Dr. Mark Popovsky Receives Prominent Award for Leadership in Transfusion Medicine
Date:10/26/2009

BRAINTREE, Mass., Oct. 26 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE) announced today that Dr. Mark Popovsky, Vice President and Chief Medical Officer, has been awarded the Emily Cooley Memorial Award and Lectureship by AABB. The Memorial Award was founded as a lectureship in 1963 and is given annually to a person who has demonstrated teaching ability and made a major contribution to the fields of immunohematology, transfusion medicine, and cellular therapies.

"The Emily Cooley Memorial Award and Lectureship is an excellent recognition of Dr. Popovsky's dedication to and impact on the transfusion industry. We are honored to have Dr. Popovsky as part of our team and congratulate him on this award," said Brian Concannon, President and CEO of Haemonetics.

Dr. Popovsky joined Haemonetics in 2000 as Corporate Medical Director and President of the Cell Processing Division. In addition to his work at Haemonetics, he is currently an Associate Clinical Professor of Pathology at Harvard Medical School and Beth Israel Deaconess Medical Center. Dr. Popovsky currently serves on the editorial board of 5 journals. He has authored, or co-authored, over 375 publications in transfusion medicine and pathology. He is editor and co-editor of two reference books in transfusion medicine. In 2004, he served in Nigeria as a member of the U.S. President's Emergency Plan for AIDS Relief delegation to that country.

Prior to Haemonetics, Dr. Popovsky was with the American Red Cross, New England Region, where he held the positions of Medical Director and then Chief Executive Officer. He also served as Director of the Transfusion and Intravenous Services at the Mayo Clinic. Dr. Popovsky is an honors graduate of the University of Vermont, College of Medicine.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

    Contact:
    Julie Fallon
    Tel. (781) 356-9517
    Alt. Tel. (617) 320-2401

SOURCE Haemonetics Corporation


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmalink AB Receives Patent for Nefecon(R) Principle
2. Solos Endoscopy, Inc. Receives Additional Purchase Orders from National Cancer Institute and National Institute of Health for its MammoView(TM) Product Line
3. Ikaria Receives Award for Excellence by New Jersey Business & Industry Association
4. NASCSA Receives $200,000 Grant From Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs
5. Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma
6. Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
7. Solos Endoscopy, Inc. Receives Multiple Purchase Orders for its MammoView(TM) Product Line
8. WorldHeart Receives IRB Approval at First Center in the Levacor(TM) VAD BTT Clinical Trial
9. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
10. AbbeyMoor Medical Receives Category I CPT(R) Code for The Spanner(TM) Prostatic Stent Procedure
11. Ortho Clinical Diagnostics Receives FDA Approval for First Anti-HIV 1+2 Test for Use on Random Access, Integrated Laboratory Testing System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... Texas , Oct. 6, 2017   Provista, ... with more than $100 billion in purchasing power, today ... news and information. The Newsroom is the ... and industry trends, infographics, expert bios, news releases, slideshows ... having access to a wealth of resources at their ...
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of ... of excellence for the field of eating disorders, announces the opening of early ... in Orlando, Florida at the Omni Resort at ChampionsGate. , The ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor ... on sciatica in a new episode of "Success Files," which is an award-winning ... innovation and investigates each subject in-depth with passion and integrity. , Sciatica occurs ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
Breaking Medicine News(10 mins):